Stocks · Health care · Pharmaceutical Preparations

Dermata Therapeutics, Inc.

DRMA Clue Score42
United States Fiscal year ends December CIK 0001853816 Results filed 11 Aug 2026

What the insiders did Net buying

By person

12 insiders · 6 transactions
14.7×

Gerald T. Proehl holds 14.7 times base salary in stock. $4.13M of shares against $280.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Gerald T. Proehl last reported holding, valued at $1.19, the price Common Stock was last bought or sold at on the open market here, on 16 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Gerald T Proehl
President, Chairman, CEO
$97.63K (3)
—
+$97.63K
3,473,096
$4.13M
—
Munera Maria E Bedoya-Toro
SVP, Regulatory Affairs
$1.27K (1)
—
+$1.27K
85,155
$101.34K
+336.2%
Kathleen D. Scott
Director
—
$13.09 (1)
−$13.09
0
$0.00
—
David F Hale
Director
— (1)
—
$0.00
737,511
$877.71K
+170.4%
Proehl Investment Ventures LLC entity
10% owner
—
—
—
2,905,544
$3.46M
+216.7%
Hoose Kyri K. Van
SVP, CFO
—
—
—
232,463
$276.65K
—
Mary Fisher
Director
—
—
—
196,946
$234.39K
—
Wendell Wierenga
Director
—
—
—
62,398
$74.26K
+1,179%
Christopher J. Nardo
Senior VP, CDO
—
—
—
27,560
$32.80K
+9.7%
Andrew Seth Sandler
Director
—
—
—
24,184
$28.78K
—
Brittany Bradrick
Director
—
—
—
23,443
$27.90K
—
Thomas Insley
Chief Financial Officer
—
—
—
14,337
$17.06K
+47.0%

No percentages here. This company's share count has moved by a factor of 8.0 over the window, from 681,557 to 5,430,648 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.